269 related articles for article (PubMed ID: 1947810)
21. Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans.
Maraspin V; Ogrinc K; Ružić-Sabljić E; Lotrič-Furlan S; Strle F
Infection; 2011 Feb; 39(1):35-40. PubMed ID: 21153429
[TBL] [Abstract][Full Text] [Related]
22. [Skin manifestations in Lyme borreliosis. 6: Acrodermatitis chronica atrophicans (ACA)].
Hassler D
Fortschr Med; 1998 Feb; 116(5):34-6. PubMed ID: 9553302
[No Abstract] [Full Text] [Related]
23. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A
Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032
[TBL] [Abstract][Full Text] [Related]
24. The expanding spectrum of cutaneous borreliosis.
Eisendle K; Zelger B
G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
[TBL] [Abstract][Full Text] [Related]
25. [Incidence of skin manifestations of Lyme disease in Croatia].
Kansky A; Balić-Winter A; Bolanca-Bumber S; Skerlev M
Lijec Vjesn; 1992; 114(1-4):25-7. PubMed ID: 1343019
[TBL] [Abstract][Full Text] [Related]
26. [Reinfection in Lyme borreliosis].
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
Pol Merkur Lekarski; 2008 Sep; 25(147):257-9. PubMed ID: 19112844
[TBL] [Abstract][Full Text] [Related]
27. Lyme borreliosis.
Stanek G; Strle F
Lancet; 2003 Nov; 362(9396):1639-47. PubMed ID: 14630446
[TBL] [Abstract][Full Text] [Related]
28. Contributions to the treatment of dermatologic manifestations of Lyme borreliosis.
Hercogová J; Tománková M; Barták P
Cutis; 1992 Jun; 49(6):409-11. PubMed ID: 1628507
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous manifestations of Lyme borreliosis.
Berger BW
Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
[TBL] [Abstract][Full Text] [Related]
30. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
[TBL] [Abstract][Full Text] [Related]
31. Procalcitonin levels in patients with Lyme borreliosis.
Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
[TBL] [Abstract][Full Text] [Related]
32. Lyme borreliosis.
Melski JW
Semin Cutan Med Surg; 2000 Mar; 19(1):10-8. PubMed ID: 10834603
[TBL] [Abstract][Full Text] [Related]
33. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
[TBL] [Abstract][Full Text] [Related]
34. Lyme disease: the evolution of erythema chronicum migrans into acrodermatitis chronica atrophicans.
Patmas MA
Cutis; 1993 Sep; 52(3):169-70. PubMed ID: 8243101
[TBL] [Abstract][Full Text] [Related]
35. [Lyme Borreliosis: Cutaneous and Neurologic Manifestations, Case Definitions and Therapy].
Scheerer C; Dersch R; Huppertz HI; Hofmann H
Dtsch Med Wochenschr; 2020 Jan; 145(1):19-28. PubMed ID: 31914465
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of Lyme disease based on dermatologic manifestations.
Malane MS; Grant-Kels JM; Feder HM; Luger SW
Ann Intern Med; 1991 Mar; 114(6):490-8. PubMed ID: 1994797
[TBL] [Abstract][Full Text] [Related]
37. Lyme borreliosis: diagnosis and management.
Kullberg BJ; Vrijmoeth HD; van de Schoor F; Hovius JW
BMJ; 2020 May; 369():m1041. PubMed ID: 32457042
[TBL] [Abstract][Full Text] [Related]
38. [Multilocular erythema migrans in borreliosis].
Krischer S; Ott H; Barker M; Frank J; Erdmann S
Klin Padiatr; 2004; 216(4):236-7. PubMed ID: 15284948
[TBL] [Abstract][Full Text] [Related]
39. [Unusual manifestations of Lyme borreliosis. A contribution to the clinical spectrum of this disease group].
Detmar U; Maciejewski W; Link C; Breit R; Sigl H; Robl H; Preac-Mursic V
Hautarzt; 1989 Jul; 40(7):423-9. PubMed ID: 2759856
[TBL] [Abstract][Full Text] [Related]
40. [The dermatologic spectrum of Lyme borreliosis].
Aberer E
Wien Med Wochenschr; 1995; 145(7-8):165-70. PubMed ID: 7610665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
